Total retinal blood flow lower in diabetic macular edema

February 13, 2017

(HealthDay)—Total retinal blood flow (TRBF) is significantly lower in eyes of patients with diabetic macular edema (DME), according to a study published online Feb. 9 in JAMA Ophthalmology.

ByungKun Lee, from the Massachusetts Institute of Technology in Cambridge, and colleagues conducted a cross-sectional study involving 41 eyes with (DR) from 31 with diabetes, 20 eyes without DR from 11 patients with diabetes, and 16 eyes from 12 healthy age-matched controls. The authors examined TRBF using en face Doppler optical coherence tomography (OCT) raster scans.

The researchers found that the mean TRBF was 28.0, 48.8, and 40.1 µL/min in the eyes with DME, in the eyes with DR without DME, and in age-matched healthy eyes, respectively. There was no difference in TRBF for eyes with DME that were treated and eyes with DME that were not treated. Regardless of DR severity, the TRBF was consistently low in eyes with DME. The range of TRBF varied from 31.1 to 75.0 µL/min in eyes with moderate non-proliferative DR but without DME.

"High-speed en face Doppler OCT can measure TRBF in healthy and diabetic eyes," the authors write. "Further longitudinal studies of TRBF in eyes with DR would be helpful to determine whether reduced TRBF is a risk factor for DME."

Several authors disclosed financial ties to the biopharmaceutical and medical technology industries.

Explore further: Higher AlphaB-crystallin levels linked to diabetic retinopathy

More information: Full Text (subscription or payment may be required)

Related Stories

Higher AlphaB-crystallin levels linked to diabetic retinopathy

December 21, 2016
(HealthDay)—Vitreous levels of alphaB-crystallin are significantly higher in eyes of patients with proliferative diabetic retinopathy (PDR) compared to the eyes of controls without diabetes, according to a study published ...

Pilocarpine expands schlemm canal in healthy eyes, glaucoma

June 25, 2016
(HealthDay)—Pilocarpine expands the Schlemm canal in eyes with and without glaucoma, according to a study published online June 23 in JAMA Ophthalmology.

Aflibercept rescues vision after laser for diabetic macular edema

December 29, 2016
(HealthDay)—For eyes experiencing substantial visual loss after macular laser photocoagulation treatment for diabetic macular edema (DME), intravitreal aflibercept improves visual and anatomic outcomes, according to a study ...

Prevalence of diabetic macular edema varies by test

January 5, 2016
(HealthDay)—Diabetic macular edema (DME) is more often diagnosed using monocular fundus photography than optical coherence tomography (OCT) central subfield thickness (CST), according to a study published online Dec. 30 ...

Microaneurysm turnover IDs macular edema development

January 8, 2013
(HealthDay)—Microaneurysm (MA) turnover independently predicts the development of clinically significant macular edema (CSME) in patients with non-proliferative diabetic retinopathy (NPDR), according to a study published ...

Recommended for you

Newly published research provides new insight into how diabetes leads to retinopathy

December 7, 2017
An international team of scientists led by Professor Ingrid Fleming of Goethe University, Frankfurt, Germany, and including Professor Bruce Hammock of the University of California, Davis, provides new insight into the mechanism ...

Researchers use breakthrough technology to understand eclipse eye damage

December 7, 2017
In a first-of-its-kind study, Mount Sinai researchers are using adaptive optics (AO) to analyze retinal eye damage from the August solar eclipse on a cellular level. The research could help doctors develop a deeper understanding ...

Combating eye injuries with a reversible superglue seal

December 6, 2017
When a soldier sustains a traumatic eye injury on the battlefield, any delay in treatment may lead to permanent vision loss. With medical facilities potentially far away and no existing tools to prevent deterioration, medics ...

Trigger for most common form of vision loss discovered

November 27, 2017
In a major step forward in the battle against macular degeneration, the leading cause of vision loss among the elderly, researchers at the University of Virginia School of Medicine have discovered a critical trigger for the ...

Scientists engineer drug delivery device that treats glaucoma directly inside the eye

November 23, 2017
Glaucoma, which affects over 60 million people worldwide, can seem easy to treat: medicated eye drops can be used to ease the buildup of fluid in the eye that underlies the condition. If glaucoma is caught early, eye drops ...

Research reveals biological mechanism of a leading cause of childhood blindness

November 16, 2017
Scientists at the Virginia Tech Carilion Research Institute (VTCRI) have revealed the pathology of cells and structures stricken by optic nerve hypoplasia, a leading cause of childhood blindness in developed nations.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.